Molecular Designs Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Molecular Designs's estimated annual revenue is currently $8.5M per year.(i)
  • Molecular Designs's estimated revenue per employee is $155,000

Employee Data

  • Molecular Designs has 55 Employees.(i)
  • Molecular Designs grew their employee count by -18% last year.

Molecular Designs's People

NameTitleEmail/Phone
1
Founder & Scientific ConsultantReveal Email/Phone
2
Founder & Clinical AdvisorReveal Email/Phone
3
CEOReveal Email/Phone
4
Chief Commercial Officer (CCO)Reveal Email/Phone
5
General Counsel and Chief Compliance OfficerReveal Email/Phone
6
Chief Human Capital OfficerReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Chief Scientific OfficerReveal Email/Phone
9
Chief Commercial OfficerReveal Email/Phone
10
VP OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M729%N/AN/A
#2
$0.2M1-50%N/AN/A
#3
$2.6M176%N/AN/A
#4
$1.6M10-17%N/AN/A
#5
$17.5M113-3%N/AN/A
#6
$0.3M20%N/AN/A
#7
$2.5M167%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$3.4M22-15%N/AN/A
#10
$23.3M150-11%N/AN/A
Add Company

What Is Molecular Designs?

Molecular Designs develops, produces, and supplies multi-plex assays for molecular testing. We are a team of doctors and scientists who have developed molecular testing products designed to identify pathogens quickly and accurately. Our premium assays are highly sensitive and specific and can detect as little as 1-5 copies of DNA or RNA, depending on your needs. Our mission remains simple – to help end antibiotic resistance and assist our clients in improving patient outcomes. We believe the work that we are doing can make a significant impact on patient care.

keywords:N/A

N/A

Total Funding

55

Number of Employees

$8.5M

Revenue (est)

-18%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.5M5538%N/A
#2
$14.4M556%N/A
#3
$15M5512%N/A
#4
$10.4M550%N/A
#5
$7.4M5531%N/A